Cellectis S A (CLLS) Return on Investment ROI from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, average high and low, overall ranking from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cellectis S a   (NASDAQ: CLLS)


Cellectis S A's ROI from its fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cellectis S A's ROI in the fourth quarter of 2025?
Cellectis S A recorded a cumulative net loss of $-91 million during 12 months ending in the fourth quarter of 2025, resulting in a negative return on investment (ROI) of -49.01%.

Within the Healthcare sector 489 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2025 from 0 to 4004.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Investment Change TTM 3.89 % 3.89 % 38.71 % 41.6 % 83.64 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 179 179 209 179 132
Return On Investment (TTM) -49.01 % -34.64 % -32.84 % -36.53 % -34.58 %
CLLS's Overall Ranking # 4004 # 0 # # #
Seq. Investment Change TTM 6.7 % -5.2 % 8.5 % -5.34 % 6.71 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -91 -60 -60 -62 -62

CLLS Company Profile >> Back to CLLS Roi Comparisons >> See Annual CLLS Return On Investment



Return On Investment CLLS's Ranking
Within: No.
Industry # 61
Sector # 490
Overall # 4004

Return On Investment Statistics
High Average Low
-12.88 %
-32.77 %
-88.86 %
0   (Dec 31 2022)







Financial Statements
Cellectis S A's IV. Quarter Investments $ 179 Millions CLLS's Balance sheet
Cellectis S A's IV. Quarter Income $ -68 Millions Quarterly CLLS's Income Statement
CLLS's Income by Division See CLLS's Income by Division


CLLS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 77 132 87 128 241
Y / Y Investment Growth -41.56 % 51.8 % -32.17 % -46.79 % -22.91 %
Net Income in Millions -68 -37 -108 -114 -125
Y / Y Net Income Growth - - - - -
Annual Return On Investment -87.52 % -27.82 % -124.57 % -88.86 % -51.87 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CLLS's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CLLS's Competitors
Subscribers only: Roi for Cellectis S A's Suppliers
Subscribers only: Return On Investment for CLLS's Customers

Other Ratios
CLLS's Roa CLLS's Inventory Turnover Ratio CLLS's Growth Rates CLLS's Dividend Statistics
CLLS's Profitability Ratios CLLS's Asset Turnover Ratio CLLS's Dividend Growth
CLLS's Roe CLLS's Valuation Ratios CLLS's Financial Strength Ratios CLLS's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector ROI

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.